全球主動脈瘤市場-全球產業分析,規模,份額,成長,趨勢,預測(2031)-按類型、按治療、按產品、按最終用戶、按地區
市場調查報告書
商品編碼
1420353

全球主動脈瘤市場-全球產業分析,規模,份額,成長,趨勢,預測(2031)-按類型、按治療、按產品、按最終用戶、按地區

Aortic Aneurysm Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日期: | 出版商: Fairfield Market Research | 英文 296 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球主動脈瘤市場規模為39.1億美元,預計在2024年至2031年的預測期內將呈現顯著成長,預計將達到96.1億美元。

動脈粥狀硬化的盛行率日益增加及其相關風險是市場成長的主要驅動力。世界老年人口的增加大大增加了患者數量。美國衛生與公共服務部預測老年人口將大幅增加,預計到 2040 年將達到 808 億,2060 年將達到 947 億。吸菸是主動脈瘤發生的重要危險因素,全球菸草使用的盛行正在促進市場成長。對微創手術的需求不斷增長和有利的醫療報銷政策進一步推動了市場擴張。

大眾對主動脈瘤及其治療費用缺乏認識阻礙了市場的成長。與主動脈瘤治療相關的併發症,如髂骨穿孔、支架狹窄、內漏和遠端張力,是市場上的挑戰。在已開發國家,遲遲沒有用EVAR等微創手術取代傳統手術已成為值得注意的市場問題。

本報告研究了全球主動脈瘤市場,並提供了市場概述,包括按類型、治療、產品、最終用戶、區域劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第三章全球主動脈瘤市場展望,2018-2031

  • 2018-2031 年全球主動脈瘤市場前景,按類型和價值(十億美元)
  • 全球主動脈瘤市場前景(按治療方法)、價值(十億美元),2018-2031 年
  • 全球主動脈瘤市場展望,按產品,價值(十億美元),2018-2031
  • 全球主動脈瘤市場展望,按最終用戶劃分,價值(十億美元),2018-2031 年
  • 全球主動脈瘤市場展望,按地區,價值(十億美元),2018-2031

第 4 章 2018-2031 年北美主動脈瘤市場展望

第五章歐洲主動脈瘤市場展望,2018-2031

第六章 2018-2031 年亞太地區主動脈瘤市場展望

第 7 章 2018-2031 年拉丁美洲主動脈瘤市場展望

第 8 章 2018-2031 年中東和非洲主動脈瘤市場展望

第9章 競爭格局

  • 按產品和處理劃分的熱圖
  • 按製造商和處理方式劃分的熱圖
  • 2023 年公司市場份額分析
  • 比賽儀表板
  • 公司簡介
    • Medtronic
    • Endologix LLC
    • Gore Medical
    • MicroPort Scientific Corporation
    • Cook
    • JOTEC
    • Cardinal Health
    • Terumo Corporation
    • Lombard Medical
    • AbbVie Inc.

第10章附錄

簡介目錄

The global aortic aneurysm market, valued at US$ 3.91 Billion in 2024, is set to exhibit remarkable growth during the forecast period from 2024 to 2031. This substantial growth trajectory aims to accumulate a market value of US$ 9.61 Billion by 2031.

Factors Driving Market Growth:

The growth of the aortic aneurysm market can be attributed to several pivotal factors:

  • Increasing Prevalence of Atherosclerosis: The rising incidence of atherosclerosis and its associated risks have become major drivers of market growth.
  • Rising Geriatric Population: The expanding elderly population globally is contributing significantly to the patient pool. The U.S. Department of Health and Human Services predicts a substantial increase in the elderly population, reaching 80.8 Billion by 2040 and 94.7 Billion by 2060.
  • Smoking-Related Risk: Smoking is a significant risk factor for developing aortic aneurysms, and the global prevalence of tobacco use is contributing to the market growth.
  • Minimally Invasive Procedures: The increasing demand for minimally invasive procedures and favorable health reimbursement policies are further augmenting market expansion.

Challenges Faced by the Aortic Aneurysm Market:

Despite the positive growth prospects, the market faces certain challenges, including-

  • Lack of Awareness: Limited awareness among the general public about aortic aneurysms and the cost associated with their treatment is hampering market growth.
  • Complications: Complications related to aortic aneurysm treatment, such as iliac perforation, stent stenosis, endoleaks, and end tension, pose challenges to the market.
  • Traditional vs. Minimally Invasive Procedures: The slow replacement of traditional surgical procedures by minimally invasive surgeries, such as EVAR, in advanced countries is a noteworthy market challenge.

Regional Insights:

  • North America: Rapid technological advancements, a shift toward minimally invasive procedures, and the implementation of health screening programs have positioned North America as a prominent market, accounting for 47% of the aortic aneurysm market share in 2022.
  • Europe: Europe's significant market share can be attributed to technological advancements and the high prevalence of atherosclerosis. National organizations, such as the National Health Service (NHS), are actively working to reduce aortic aneurysm incidences.
  • Asia Pacific: The Asia Pacific region is expected to witness substantial growth due to a rising aging population, an increased prevalence of cardiovascular diseases, and growing disposable income. The presence of a sizable aging population is favoring market expansion.

Competitive Analysis:

Key players in the aortic aneurysm market are actively involved in research, product development, and collaborations to enhance their market presence. Some notable developments include:

  • In March 2021, Cook Medical, Inc. received FDA breakthrough device designation for Zenith Fenestrated+ Endovascular Graft (ZFEN+), used in treating intravascular AA.
  • Endologix LLC is expanding its geographical presence by selling EVAR products in multiple countries, including the U.S., Canada, New Zealand, South Korea, and Europe.

Key Companies Profiled:

  • Medtronic
  • Endologix LLC
  • Gore Medical
  • MicroPort Scientific Corporation
  • Cook
  • JOTEC
  • Cardinal Health
  • Terumo Corporation
  • Lombard Medical
  • AbbVie Inc.

Key Segments Profiled in the Aortic Aneurysm Industry Survey

Aortic Aneurysm by Type

  • Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
  • Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)

Aortic Aneurysm Treatment

  • Aortic Aneurysm by Open Surgical Repair (OSR)
  • Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)

Aortic Aneurysm Product

  • Aortic Aneurysm by Stent Grafts
  • Aortic Aneurysm by Catheters

Aortic Aneurysm End User

  • Aortic Aneurysm by Hospitals
  • Aortic Aneurysm by Ambulatory Surgery Centers
  • Aortic Aneurysm by Clinics

Aortic Aneurysm Region

  • North America Aortic Aneurysm Market
  • Latin America Aortic Aneurysm Market
  • Europe Aortic Aneurysm Market
  • Asia Pacific Aortic Aneurysm Market
  • Middle East & Africa Aortic Aneurysm Market

Table of Contents

1. Executive Summary

  • 1.1. Global Aortic Aneurysm Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aortic Aneurysm Market Outlook, 2018 - 2031

  • 3.1. Global Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 3.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 3.2. Global Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 3.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 3.3. Global Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Aortic Aneurysm by Stent Grafts
      • 3.3.1.2. Aortic Aneurysm by Catheters
  • 3.4. Global Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Aortic Aneurysm by Hospitals
      • 3.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 3.4.1.3. Aortic Aneurysm by Clinics
  • 3.5. Global Aortic Aneurysm Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Aortic Aneurysm Market Outlook, 2018 - 2031

  • 4.1. North America Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 4.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 4.2. North America Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 4.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 4.3. North America Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Aortic Aneurysm by Stent Grafts
      • 4.3.1.2. Aortic Aneurysm by Catheters
  • 4.4. North America Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Aortic Aneurysm by Hospitals
      • 4.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 4.4.1.3. Aortic Aneurysm by Clinics
  • 4.5. North America Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aortic Aneurysm Market Outlook, 2018 - 2031

  • 5.1. Europe Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 5.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 5.2. Europe Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 5.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 5.3. Europe Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Aortic Aneurysm by Stent Grafts
      • 5.3.1.2. Aortic Aneurysm by Catheters
  • 5.4. Europe Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Aortic Aneurysm by Hospitals
      • 5.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 5.4.1.3. Aortic Aneurysm by Clinics
  • 5.5. Europe Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aortic Aneurysm Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 6.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 6.2. Asia Pacific Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 6.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 6.3. Asia Pacific Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Aortic Aneurysm by Stent Grafts
      • 6.3.1.2. Aortic Aneurysm by Catheters
  • 6.4. Asia Pacific Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Aortic Aneurysm by Hospitals
      • 6.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 6.4.1.3. Aortic Aneurysm by Clinics
  • 6.5. Asia Pacific Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aortic Aneurysm Market Outlook, 2018 - 2031

  • 7.1. Latin America Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 7.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 7.2. Latin America Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 7.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 7.3. Latin America Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Aortic Aneurysm by Stent Grafts
      • 7.3.1.2. Aortic Aneurysm by Catheters
  • 7.4. Latin America Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Aortic Aneurysm by Hospitals
      • 7.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 7.4.1.3. Aortic Aneurysm by Clinics
  • 7.5. Latin America Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aortic Aneurysm Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 8.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 8.2. Middle East & Africa Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Peripheral Arterial Disease
      • 8.2.1.2. Peripheral Aneurysms
      • 8.2.1.3. In Stent Restenosis
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Aortic Aneurysm by Stent Grafts
      • 8.3.1.2. Aortic Aneurysm by Catheters
  • 8.4. Middle East & Africa Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Aortic Aneurysm by Hospitals
      • 8.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 8.4.1.3. Aortic Aneurysm by Clinics
  • 8.5. Middle East & Africa Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Treatment Heatmap
  • 9.2. Manufacturer vs Treatment Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Medtronic
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Endologix LLC
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Gore Medical
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. MicroPort Scientific Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Cook
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. JOTEC
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Cardinal Health
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Terumo Corporation
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Lombard Medical
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. AbbVie Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations